PA

Pankaj Arun Dantwala

Active Director Director DIN 02158836
DIN 02158836 First appointment Jun 2001 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Jun 2001
Shareholding value β€’β€’β€’β€’ Premium profile

About Pankaj Arun Dantwala

Data last updated:

Pankaj Arun Dantwala is a Director at Jenburkt Pharmaceuticals Ltd (since 2024), Director at Clover Infoservices Private Limited (since 2024) and Director at Kalzoom Technologies Private Limited (since 2003), and holds 1 more current directorship. The companies operate in Pharma, Information Technology and Business Services. The largest current company by reported revenue is Jenburkt Pharmaceuticals Ltd at ₹158 Cr (FY 2025). Earlier, Pankaj Arun Dantwala was a Director at Natarajan Empowerment Foundation (2024–2025) and Director at Global Talent Track Private Limited (2008) and 1 more.

DIN 02158836
Primary Designation Director
Industry Pharma
First Appointment 08 Jun 2001
Oldest Company Age 41 yrs
Largest company Jenburkt Pharmaceuticals Ltd Β· ₹158 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jenburkt Pharmaceuticals Ltd L24230MH1985PLC036541
Director28 May 20241985₹158 Cr (FY 2025)Active
Clover Infoservices Private Limited U62099MH2024PTC425017
Director10 May 20242024Active
Kalzoom Technologies Private Limited U72900MH2003PTC138726
Director17 Jan 20032003Active
Director08 Jun 20012001Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Natarajan Empowerment Foundation U85500PN2024NPL230399
Director24 Apr 20242024Active
Global Talent Track Private Limited U74999PN2008PTC132520
Director31 Jul 20082008₹4.18 Cr (FY 2025)Active
Director09 Dec 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kalzoom Technologies Private Limited
Kalzoom Management Service Technologies Private Limited
Gufi Multimedia Entertainment Private Limited
Jenburkt Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Pankaj Arun Dantwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Arun Dantwala

Pankaj Arun Dantwala currently holds 4 directorships: Jenburkt Pharmaceuticals Ltd (Director, since 28 May 2024, revenue β‚Ή158 Cr (FY 2025)); Clover Infoservices Private Limited (Director, since 10 May 2024); Kalzoom Technologies Private Limited (Director, since 17 Jan 2003); Kalzoom Management Service Technologies Private Limited (Director, since 08 Jun 2001).

Pankaj Arun Dantwala was first appointed on 08 Jun 2001 as Director at Kalzoom Management Service Technologies Private Limited. The most recent appointment on record is 28 May 2024 at Jenburkt Pharmaceuticals Ltd.

Pankaj Arun Dantwala held 3 earlier board appointments: Natarajan Empowerment Foundation (Director, 24 Apr 2024 to 01 Aug 2025); Global Talent Track Private Limited (Director, 31 Jul 2008 to 13 Oct 2008); Gufi Multimedia Entertainment Private Limited (Director, from 09 Dec 2005).

The current boards of Pankaj Arun Dantwala's companies include Ashish Rasiklal Shah (Jenburkt Pharmaceuticals Ltd), Ashish Uttam Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Hina Ravindra Mehta (Jenburkt Pharmaceuticals Ltd), Krishnan Subharaman (Jenburkt Pharmaceuticals Ltd), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available